We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

The Alzheimer's Association of Greater Kentucky and Southern Indiana held the kickoff party on Wednesday for its Walk to End ...

A free database of biomarker information on neurodegenerative diseases was released with backing from Bill Gates, Johnson & ...

Living with Alzheimer’s disease can be both challenging and frightening. However, stories of resilience and hope can inspire ...

Learn about the challenges of caring for a loved one with Alzheimer's disease and the importance of awareness and support.

New University of Virginia School of Medicine research suggests an unexpected way doctors may be able to improve blood flow ...

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...

In Canada, "the average lifespan of someone with Down syndrome is about 60 years old," said Dr. Brian Skotko, senior author ...

Scientists at The Jackson Laboratory are working on a promising diagnostic tool that could identify Alzheimer’s disease and other forms of dementia decades before symptoms appear.

Stroke kills millions, but Osaka researchers have unveiled GAI-17, a drug that halts toxic GAPDH clumping, slashes brain ...